Attention Purchasers of Inktomi Corporation Securities: Rabin & Peckel LLP Commences Class Action Against Merrill Lynch & Co., Inc., Morgan Stanley Dean Witter & Co., Inc., Henry Blodget, and Mary Meeker Alleging Violations of Federal Securities Law -- INKT


NEW YORK, Oct. 7, 2002 (PRIMEZONE) -- A class action Complaint has been filed in the United States District Court for the Southern District of New York, on behalf of all persons or entities who purchased or otherwise acquired securities of Inktomi Corporation ("Inktomi") (Nasdaq:INKT) between June 10, 1998 and April 3, 2001, both dates inclusive (the "Class Period"). Merrill Lynch & Co., Inc., Morgan Stanley Dean Witter & Co., Inc., Henry Blodget, and Mary Meeker are named as defendants in the complaint.

To discuss this action, this announcement, or your rights or interests, please contact plaintiff's counsel, Eric J. Belfi or Sharon Lee, Rabin & Peckel LLP, 275 Madison Avenue, New York, NY 10016, by telephone at (800) 497-8076 or (212) 682-1818, by facsimile at (212) 682-1892, or by e-mail at email@rabinlaw.com.

The complaint charges Merrill Lynch & Co., Inc. ("Merrill Lynch"), Morgan Stanley Dean Witter & Co., Inc. ("Morgan Stanley"), Henry Blodget, and Mary Meeker with issuing misleading analyst reports about Inktomi. Specifically, the complaint alleges that defendants issued and maintained "Buy" recommendations about Inktomi without any rational economic basis; failed to disclose that they were issuing and maintaining "Buy" recommendations to obtain investment banking business; and concealed significant, material conflicts of interests that prevented them from providing independent objective analysis.

Plaintiff is represented by the law firm of Rabin & Peckel LLP. Rabin & Peckel LLP and its predecessor firms have devoted its practice to shareholder class actions and complex commercial litigation for more than thirty years and have recovered hundreds of millions of dollars for shareholders in class actions throughout the United States. You can learn more information about Rabin & Peckel LLP at www.rabinlaw.com.

If you purchased or otherwise acquired Inktomi securities during the Class Period described above, you may, no later than October 29, 2002, move the Court to serve as lead plaintiff. To serve as lead plaintiff, however, you must meet certain legal requirements. You can join this action as a lead plaintiff online at www.rabinlaw.com. Contact plaintiff's counsel Eric J. Belfi or Sharon Lee of Rabin & Peckel LLP to further discuss this action, this announcement, or your rights or interests.

More information on this and other class actions can be found on the Class Action Newsline at www.primezone.com/ca.



            

Contact Data